Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
about
Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatmentMissense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levelsThe perception and endogenous modulation of painTriple Reuptake Inhibitors: A Premise and PromiseFibromyalgia: presentation and management with a focus on pharmacological treatment.Psychological Resilience, Affective Mechanisms and Symptom Burden in a Tertiary-care Sample of Patients with Fibromyalgia.Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue.Descending pain modulation and chronification of pain.Neuroplasticity underlying the comorbidity of pain and depressionTypology of patients with fibromyalgia: cluster analysis of duloxetine study patientsEfficacy of transcranial direct current stimulation coupled with a multidisciplinary rehabilitation program for the treatment of fibromyalgia.Pain Sensitivity and Pain Catastrophizing Are Associated With Persistent Pain and Disability After Lumbar Spine SurgeryPalmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.Duloxetine in OsteoArthritis (DOA) study: study protocol of a pragmatic open-label randomised controlled trial assessing the effect of preoperative pain treatment on postoperative outcome after total hip or knee arthroplasty.Newer treatments for fibromyalgia syndrome.Visceral analgesics: drugs with a great potential in functional disorders?Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.The determination and application of fixed-dose analgesic combinations for treating multimodal pain.Emerging therapies for fibromyalgia: an update.Pharmacological treatment of chronic non-cancer pain in pediatric patients.An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.Cortical and subcortical modulation of pain.Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.Pharmacological Management of Chronic Pelvic Pain in Women.Rational combination therapy in refractory migraine.Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.The role of stress in rheumatic diseases.Fibromyalgia: new hope for a medical dilemma.PhenotypicIn VivoScreening to Identify New, Unpredicted Indications for Existing Drugs and Drug Candidates
P2860
Q21296574-48120F7F-ED7B-49D5-B372-02E025866571Q24293495-A5F90ECA-DAB9-4260-9E39-9AD681EAC5A3Q27011310-1A6C79CA-BB71-42D4-BD66-0064B7F79282Q28972234-37EA5136-E9BD-4459-A3F0-A511D692CFE9Q33562399-8AB16E82-455D-4B38-BA00-C8DABFCFC51FQ33831726-8E9A9607-13BF-4E5B-AA1C-8F00CBB868B7Q34345848-04B7FBD1-541D-4D47-B992-56B6101EC231Q34993456-D53163BB-11DC-49CD-9DD5-4E31AAC35821Q35165267-0C47D610-39B8-4011-ADF2-D70E6F09C1C6Q35191443-39A95794-A2F5-4014-B469-DD098CAAD7A9Q35480320-538109E3-93C1-4399-9610-2E14E07CA1AAQ36149078-B3595FB0-54DA-4E55-954A-58C143925C42Q36365821-AD46F9A7-7081-4B73-9F16-7ABD277ACB7CQ36670614-6D1E1A86-DC7A-41AF-9369-DAC14C92A51CQ37098174-2DED6274-AECF-459D-B1EE-F1E95236C8E2Q37118821-866426A0-5BC0-4590-AA91-380CA94166D5Q37350354-96B6ADDD-C1BE-42DF-AABC-C58ED1C70E83Q37719166-F1336573-C762-4A8C-944A-486D0BFC8F99Q37756999-35DB285A-6F21-473F-9E2E-2E604169B3E0Q38258949-75FDF1F5-7846-45D2-BD76-814AFE0D1ECCQ38613235-99B38887-DB29-4926-84D1-2107EACD7CB4Q38777501-7A519BFD-8676-4351-88B3-3A87F337737AQ38832018-10B58D7A-D7E4-46D5-BD17-D466028368A7Q39078993-E4385CBF-590B-4C13-AAA2-A8F0D832EFA1Q40081930-E3FAE0CB-8074-463F-8541-FA2F452669E8Q42595188-CDF2EAE3-D06C-478D-ADAD-F5122937B67EQ42663991-48B79BBC-E4A6-4DA0-8827-985E49369EB3Q46889981-7E9FF2C2-1EB3-40BD-A04C-2ED29DFC44A0Q56610263-70DDD73F-877C-420E-A16B-DDFE040E7316
P2860
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
@en
type
label
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
@en
prefLabel
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
@en
P1433
P1476
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
@en
P304
P356
10.1111/J.1526-4637.2006.00178.X
P478
P577
2007-09-01T00:00:00Z